References
- Alibek K, Kakpenova A, Baiken Y (2013). Role of infectious agents in the carcinogenesis of brain and head and neck cancers. Infect Agent Cancer, 8, 7. https://doi.org/10.1186/1750-9378-8-7
- Cobbs CS (2011). Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis. Herpesviridae, 2, 10. https://doi.org/10.1186/2042-4280-2-10
- Costa B, Bendinelli S, Gabelloni P, et al (2013). Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor. PLoS One, 8, e72281. https://doi.org/10.1371/journal.pone.0072281
- Del Valle L, Azizi SA, Krynska B, et al (2000). Reactivation of human neurotropic JC virus expressing oncogenic protein in a recurrent glioblastoma multiforme. Ann Neurol, 48, 932-6. https://doi.org/10.1002/1531-8249(200012)48:6<932::AID-ANA15>3.0.CO;2-E
- Del Valle L, Delbue S, Gordon J, et al (2002). Expression of JC virus T-antigen in a patient with MS and glioblastoma multiforme. Neurology, 58, 895-900. https://doi.org/10.1212/WNL.58.6.895
- Devireddy LR, Kumar KU, Pater MM, et al (1996). Evidence for a mechanism of demyelination by human JC virus: negative transcriptional regulation of RNA and protein levels from myelin basic protein gene by large tumor antigen in human glioblastoma cells. J Med Virol, 49, 205-11. https://doi.org/10.1002/(SICI)1096-9071(199607)49:3<205::AID-JMV8>3.0.CO;2-8
- Djuzenova CS, Fiedler V, Memmel S, et al (2015). Actin cytoskeleton organization, cell surface modification and invasion rate of 5 glioblastoma cell lines differing in PTEN and p53 status. Exp Cell Res, 330, 346-57. https://doi.org/10.1016/j.yexcr.2014.08.013
- Dos Santos CJ, Stangherlin LM, Figueiredo EG, et al (2014). High prevalence of HCMV and viral load in tumor tissues and peripheral blood of glioblastoma multiforme patients. J Med Virol, 86, 1953-61. https://doi.org/10.1002/jmv.23820
- Ghazi A, Ashoori A, Hanley PJ, et al (2012). Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma. J Immunother, 35, 159-68. https://doi.org/10.1097/CJI.0b013e318247642f
- Knight A, Arnouk H, Britt W, et al (2013). CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vdelta1+ gammadelta T cells. PLoS One, 8, e68729. https://doi.org/10.1371/journal.pone.0068729
- Lehrer S, Green S, Ramanathan L, et al (2012). No consistent relationship of glioblastoma incidence and cytomegalovirus seropositivity in whites, blacks, and Hispanics. Anticancer Res, 32, 1113-5.
- Lucas KG, Bao L, Bruggeman R, et al (2011). The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neurooncol, 103, 231-8. https://doi.org/10.1007/s11060-010-0383-6
- Major EO, Mourrain P, Cummins C (1984). JC virus-induced owl monkey glioblastoma cells in culture: biological properties associated with the viral early gene product. Virol J, 136, 359-67. https://doi.org/10.1016/0042-6822(84)90172-7
- Matlaf LA, Harkins LE, Bezrookove V, et al (2013). Cytomegalovirus pp71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor. PLoS One, 8, e68176. https://doi.org/10.1371/journal.pone.0068176
- Nair SK, De Leon G, Boczkowski D, et al (2014). Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells. Clin Cancer Res, 20, 2684-94. https://doi.org/10.1158/1078-0432.CCR-13-3268
- Ottenhausen M, Bodhinayake I, Schaefer PM, et al (2014). VIGAS and beyond: the impact of HCMV-infection and its treatment in glioblastoma. J Neurosurg, 74, 23-4. https://doi.org/10.1227/01.neu.0000442982.91829.da
- Pina-Oviedo S, De Leon-Bojorge B, Cuesta-Mejias T, et al (2006). Glioblastoma multiforme with small cell neuronallike component: association with human neurotropic JC virus. Acta Neuropathol, 111, 388-96. https://doi.org/10.1007/s00401-006-0050-3
- Poch E, Minambres R, Mocholi E, et al (2007). RhoE interferes with Rb inactivation and regulates the proliferation and survival of the U87 human glioblastoma cell line. Exp Cell Res, 313, 719-31. https://doi.org/10.1016/j.yexcr.2006.11.006
- Price RL, Song J, Bingmer K, et al (2013). Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations. Cancer Res, 73, 3441-50. https://doi.org/10.1158/0008-5472.CAN-12-3846
- Sabbatino F, Fusciello C, Somma D, et al (2014). Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase I inhibitor or radiation. Cytometry A, 85, 953-61. https://doi.org/10.1002/cyto.a.22563
- Scheurer ME, Bondy ML, Aldape KD, et al (2008). Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol, 116, 79-86. https://doi.org/10.1007/s00401-008-0359-1
- Tognon M, Casalone R, Martini F, et al (1996). Large T antigen coding sequences of two DNA tumor viruses, BK and SV40, and nonrandom chromosome changes in two glioblastoma cell lines. Cancer Genet Cytogenet, 90, 17-23. https://doi.org/10.1016/0165-4608(96)00067-2
- Zhang W, Fulci G, Wakimoto H, et al (2013). Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models. Neoplasia, 15, 591-9. https://doi.org/10.1593/neo.13158